Clinical investigation has elucidated that JAK/STAT pathways are activated in peripheral blood mononuclear cells (PBMCs), glomeruli, and renal tubulointerstitium of patients with FSGS, particularly STAT1 and STAT3 pathways [54]. The gene discussed is STAT1; the disease is focal segmental glomerulosclerosis.